COVID

Milestones :: Perspectives :: Research

 

COVID

Editor’s Note:
As is obvious to all, the sheer volume of strategic announcements, regulatory actions, country program decisions, commentary, and, indeed, misinformation around COVID response continues at extraordinary levels. Our weekly digest strives to present a coherent and comprehensive snapshot, but cannot be exhaustive, If you recognize a missed strategic development, a new source of rigorous analysis, or an insight/commentary that would benefit our common understanding, please advise me…we will review all suggestions and consider for inclusion in a subsequent edition: david.r.curry@ge2p2global.org

We are seeking access to modelling which engages scenarios and articulates imperatives around a pandemic end-game through at least a 2025 horizon. We assess that WHO must be conducting or contracting for such modeling – or should recognize an imperative to be doing so in its global health governance role. If we have missed such modeling in progress, we would be delighted to be advised of it and will include it in our coverage.

COVID Vaccines – OCHA:: HDX

Milestones :: Perspectives :: Research

 

COVID Vaccines – OCHA:: HDX

COVID-19 Data Explorer: Global Humanitarian Operations
COVID-19 Vaccine Roll-out
Jul 24, 2021 | COVAX (WHO,GAVI,CEPI), UNDESA, Press Reports | DATA

 

Global COVID-19 Figures: 192M total confirmed cases; 4.1M total confirmed deaths
Global vaccines administered: 3.83B
Number of Countries: 26 [26]
COVAX First Allocations (Number of Doses): 73M [73M]
COVAX Delivered (Number of Doses): 28M [22M]
Other Delivered (Number of Doses): 52M [52M]
Total Delivered (Number of Doses): 80M [75M]
Total Administered (Number of Doses): 76M [70M]

Coronavirus [COVID-19] – WHO

Milestones :: Perspectives :: Research

 

Coronavirus [COVID-19] – WHO
Public Health Emergency of International Concern (PHEIC)
https://www.who.int/emergencies/diseases/novel-coronavirus-2019

 

Weekly Epidemiological and Operational updates
Last update: 2 Jul 2021
Confirmed cases :: 192 284 207 [week ago: 188 655 968]
Confirmed deaths :: 4 136 518 [week ago 4 067 517]
Vaccine doses administered: 3 605 386 928 [week ago: 3 402 275 866]

Weekly operational update on COVID-19 – 20 July 2021

Milestones :: Perspectives :: Research

 

Weekly operational update on COVID-19 – 20 July 2021
Overview
In this edition of the COVID-19 Weekly Operational Update, highlights of country-level actions and WHO support to countries include:
Strengthening clinical management of COVID-19 in Ghana
Receiving 2 million doses of COVID-19 vaccines in Viet Nam donated by the United States of America through the COVAX Facility
COVID-19 readiness and response at Points of Entry in Armenia
Planning and decentralization in Mumbai, India to fight the second COVID-19 surge
Receiving 500 000 vaccines in Haiti donated by the United States of America through the COVAX Facility
Enhancing resilience among parents and children in the Syrian Arab Republic through the “My Hero is You” mental health campaign
Exploring the use of WHO’s COVID-19 vaccination online learning in countries
Progress on a subset of indicators from the SPRP 2021 Monitoring and Evaluation Framework
Updates on WHO’s financing to support countries in SPRP 2021 implementation and provision of critical supplie

Weekly epidemiological update on COVID-19 – 20 July 2021
Overview
The global number of new cases reported last week (12-18 July 2021) was over 3.4 million, a 12% increase as compared to the previous week. Globally, COVID-19 case weekly incidence increased with an average of around 490 000 cases reported each day over the past week as compared to 400 000 cases daily in the previous week. Following a steady decline for over two months, the number of weekly deaths reported was similar to the previous week, with almost 57 000 deaths reported. The cumulative number of cases reported globally is now over 190 million and the number of deaths exceeds 4 million.

In this edition, two special focus updates are provided:
:: The release of a WHO COVID-19 detailed surveillance data dashboard, including a downloadable database feature.
:: A detailed update on the phenotypic characteristics (transmissibility, disease severity, risk of reinfection, and impacts on diagnostics and vaccine performance) of SARS-CoV-2 Variants of Concern (VOCs) Alpha, Beta, Gamma and Delta. It also includes updates on the geographic distribution of VOCs.

[Full scale version at link above]

Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process 26 June 2021

Milestones :: Perspectives :: Research

 

Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process 26 June 2021
For 22 vaccine candidates, presents Manufacturer, Name of Vaccine, NRA of Record, Platform, EOI Accepted Status, Pre-submission Meeting Held Status, Dossier Accepted for Review, Status of Assessment; Anticipated/Completed Decision Date
[No update since 15 July 2021; click on the link above for full scale view]

COVID Vaccine Developer/Manufacturer Announcements [relevant press releases/announcement from organizations from WHO EUL/PQ listing above]

Milestones :: Perspectives :: Research

 

COVID Vaccine Developer/Manufacturer Announcements [relevant press releases/announcement from organizations from WHO EUL/PQ listing above]

 

AstraZeneca
Press Releases
Vaxzevria is highly effective after one dose against severe disease or hospitalisation caused by Beta and Delta variants of concern
23 July 2021
Real-world data from Canada showed 82% and 87% effectiveness after one dose against hospitalisation or death caused by Beta/Gamma and Delta variants respectively

BioCubaFarma – Cuba
Últimas Noticias
[Website not responding at inquiry]

 

CanSinoBIO
News – No new digest announcements identified

Clover Biopharmaceuticals – China
News – No new digest announcements identified

 

Curevac [Bayer Ag – Germany]
News – No new digest announcements identified

 

Gamaleya National Center
Latest News and Events – No new digest announcements identified [See Russia/RFID below]

IMBCAMS, China
Home – No new digest announcements identified

 

Janssen/JNJ
Press Releases – No new digest announcements identified

 

Moderna
Press Releases
July 23, 2021
EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for the Use of the Moderna COVID-19 Vaccine in Adolescents (12-17 Years of Age) in the European Union

July 22, 2021
Moderna Announces New Supply Agreement with Taiwan for 20 Million Doses of Moderna’s COVID-19 Vaccine and Variant Booster Vaccine Candidate in 2022 and 15 Million Doses in 2023

July 20, 2021
Moderna Partners with Takeda and the Government of Japan to Supply Additional 50 Million Doses of Moderna’s COVID-19 Vaccine and Variant Booster Vaccine Candidate in 2022

 

Novavax
Press Releases – No new digest announcements identified

 

Pfizer
Recent Press Releases
7.23.2021
Pfizer and BioNTech to Provide U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.

07.21.2021
Pfizer and BioNTech Announce Collaboration With Biovac to Manufacture and Distribute COVID-19 Vaccine Doses Within Africa

07.19.2021
Valneva and Pfizer Complete Recruitment for Phase 2 Trial of Lyme Disease Vaccine Candidate

 

Sanofi Pasteur
Press Releases – No new digest announcements identified

 

Serum Institute of India
NEWS & ANNOUNCEMENTS – No corporate announcements identified
[Last media release still posted is dated February 15, 2021; media release of April 21, 2021 apparently removed]

 

Sinopharm/WIBPBIBP
News – No new digest announcements identified

 

Sinovac
Press Releases – No new digest announcements identified

 

Vector State Research Centre of Viralogy and Biotechnology
Home – No new digest announcements identified

Zhifei Longcom, China
[Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.]
[No website identified]

 

::::::

GSK
Press releases for media – No new digest announcements identified

 

SK Biosciences
Press releases – No new digest announcements identified

Countries receiving World Bank support for vaccines

Milestones :: Perspectives :: Research

 

World Bank Vaccine Operations Portal
https://www.worldbank.org/en/who-we-are/news/coronavirus-covid19/world-bank-support-for-country-access-to-covid-19-vaccines
Countries receiving World Bank support for vaccines
As of July 1, 2021
This list of countries, project documents, and procurement notices and contracts will be updated as data becomes available.

The Race for Global COVID-19 Vaccine Equity

Milestones :: Perspectives :: Research

 

Duke – Launch and Scale Speedometer

The Race for Global COVID-19 Vaccine Equity
A flurry of nearly 200 COVID-19 vaccine candidates are moving forward through the development and clinical trials processes at unprecedented speed; more than ten candidates are already in Phase 3 large-scale trials and several have received emergency or limited authorization. Our team has aggregated and analyzed publicly available data to track the flow of procurement and manufacturing and better understand global equity challenges. We developed a data framework of relevant variables and conducted desk research of publicly available information to identify COVID vaccine candidates and status, deals and ongoing negotiations for procurement and manufacturing, COVID burden by country, and allocation and distribution plans. We have also conducted interviews with public officials in key countries to better understand the context and challenges facing vaccine allocation and distribution
[accessed 24 July 2021]
See our COVID Vaccine Purchases research
See our COVID Vaccine Manufacturing research
See our COVID Vaccine Donations & Exports research

Coronavirus (COVID-19) Vaccinations[Accessed 24 Jul 2021]

Milestones :: Perspectives :: Research

 

Our World in Data
Coronavirus (COVID-19) Vaccinations[Accessed 24 Jul 2021]
27.1% of the world population has received at least one dose of a COVID-19 vaccine, and 13.6% is fully vaccinated.
3.83 billion doses have been administered globally, and 30.86 million are now administered each day.
Only 1.1% of people in low-income countries have received at least one dose.

U.S.: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

Milestones :: Perspectives :: Research

 

U.S.: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

Vaccines and Related Biological Products Advis ory Committee
:: No meetings scheduled

 

::::::

White House [U.S.]
Briefing Room – Selected Major COVID Announcements
Press Briefing by White House COVID-19 Response Team and Public Health Officials
July 22, 2021 • Press Briefings

Europe: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

Milestones :: Perspectives :: Research

 

Europe: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

 

European Medicines Agency
News & Press Releases
News: COVID-19 vaccine Spikevax approved for children aged 12 to 17 in EU (new)
CHMP, Last updated: 23/07/2021
EMA’s human medicines committee (CHMP) has recommended granting an extension of indication for the COVID-19 vaccine Spikevax (previously COVID-19 Vaccine Moderna) to include use in children aged 12 to 17 years. The vaccine is already authorised for use in people aged 18 and above…

 

News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 July 2021 (new)
CHMP, Last updated: 23/07/2021

 

News: COVID-19 Vaccine Janssen: Guillain-Barré syndrome listed as a very rare side effect (new)
PRAC, Last updated: 22/07/2021

 

News: EMA starts rolling review of COVID-19 vaccine Vidprevtyn (new)
CHMP, Last updated: 20/07/2021
EMA’s human medicines committee (CHMP) has started a rolling review of Vidprevtyn, a COVID-19 vaccine developed by Sanofi Pasteur.

 

::::::

European Centre for Disease Prevention and Control
https://www.ecdc.europa.eu/en
Latest Updates
News
SARS-COV-2 Delta variant now dominant in much of the European Region and efforts must be reinforced to prevent transmission, warn WHO/Europe and ECDC
Press release – 23 Jul 2021

Publication
Partial COVID-19 vaccination, vaccination following SARS-CoV-2 infection and heterologous vaccination schedule: summary of evidence
Technical report – 22 Jul 2021

 

::::::

 

 

Data as of 2021-07-24

https://vaccinetracker.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html#uptake-tab

 

::::::

European Commission
https://ec.europa.eu/commission/presscorner/home/en
Press release 23 July 2021
Application of EU Law in 2020: Protecting our agreed rules and shared values during a pandemic

Press release 22 July 2021
Vaccinating the world: ‘Team Europe’ to share more than 200 million doses of COVID-19 vaccines with low and middle-income countries by the end of 2021
Ensuring access to safe and affordable COVID-19 vaccines around the world, and notably for low and middle-income countries, is a priority for the European Union.

Press release 22 July 2021
Coronavirus: Commission steps up research funding with €120 million for 11 new projects to tackle the virus and its variants
The Commission has short-listed 11 new projects worth €120 million from Horizon Europe, the biggest European research and innovation programme (2021-2027), for supporting and enabling urgent research into the coronavirus and its variants.

 

::::::

Africa: COVID-19 – Announcements/Regulatory Actions/Deployment

Current at 21 Jul 2021; Full scale, interactive dashboard available at: https://africacdc.org/covid-19-vaccination/

 

::::::

Pfizer and BioNTech Announce Collaboration With Biovac to Manufacture and Distribute COVID-19 Vaccine Doses Within Africa
07.21.2021
NEW YORK & MAINZ, Germany–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the signing of a letter of intent with The Biovac Institute (Pty) Ltd, known as “Biovac,” a Cape Town-based, South African biopharmaceutical company, to manufacture the Pfizer-BioNTech COVID-19 Vaccine for distribution within the African Union.
Biovac will perform manufacturing and distribution activities within Pfizer’s and BioNTech’s global COVID-19 vaccine supply chain and manufacturing network, which will now span three continents and include more than 20 manufacturing facilities. To facilitate Biovac’s involvement in the process, technical transfer, on-site development and equipment installation activities will begin immediately.
Pfizer and BioNTech expect that Biovac’s Cape Town facility will be incorporated into the vaccine supply chain by the end of 2021. Biovac will obtain drug substance from facilities in Europe, and manufacturing of finished doses will commence in 2022. At full operational capacity, the annual production will exceed 100 million finished doses annually. All doses will exclusively be distributed within the 55 member states that make up the African Union…

Russia: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

Milestones :: Perspectives :: Research

 

Russia: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment
Russia: Sputnik V – “the first registered COVID-19 vaccine”
https://sputnikvaccine.com/newsroom/pressreleases/
Press Releases
Sputnik V approved for use in Chile
Press release, 21.07.2021

First batch of the Sputnik V vaccine produced in Vietnam
Press release, 21.07.2021
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and VABIOTECH, one of Vietnam’s leading pharmaceutical companies, announce the production of a test batch of the Russian Sputnik V vaccine against coronavirus.
The first validation samples taken from the produced batch will be shipped to the Gamaleya Center for the quality control. RDIF and VABIOTECH are actively implementing the technology transfer. Sputnik V was granted the approval by the Ministry of Health of the Socialist Republic of Vietnam on March 23, 2021…

India: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

Milestones :: Perspectives :: Research

 

India: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

 

Ministry of Health and Family Welfare
https://www.mohfw.gov.in/

 

Government of India – Press Information Bureau
Latest Press Releases
No new digest content identified.

 

Indian Council for Medical Research (ICMR)
https://www.icmr.gov.in/media.html
Press Releases
No new digest content identified.

POLIO Public Health Emergency of International Concern (PHEIC)

Emergencies

POLIO
Public Health Emergency of International Concern (PHEIC)

Polio this week as of 21 July 2021
:: In his latest blog, Bill Gates talks about the progress against polio made possible through the iron will of health workers and partners such as Rotary, GPEI’s support to COVID and new strategy to secure success. He calls on global solidarity/support to deliver on promise of polio-free world. Read more
:: The GPEI welcomes the 20th Report of the Independent Monitoring Board (IMB) which provides independent assessments of the programme to help refine and improve the GPEI’s work.

Summary of new WPV and cVDPV viruses this week (AFP cases and ES positives):
:: Ethiopia: 10 cVDPV2 cases and one cVDPV2 positive environmental sample
:: Liberia: one cVDPV2 case
:: Madagascar : two cVDPV1 cases
:: Nigeria: nine cVDPV2 case and five cVDPV2 positive environmental samples
:: Senegal: one cVDPV2 case
:: South Sudan: one cVDPV2 case

 

::::::
::::::

WHO/OCHA Emergencies

 

Editor’s Note:
WHO has apparently reorganized and fundamentally shifted how it judges and tracks “emergencies”. We found no announcement of descriptive information to share and present the webpage structure as encountered below. Obviously, the dates associated with some of these emergencies suggest that this is an archival platform as well as a current emergencies resource.

Health emergencies list – WHO
“The health emergencies list details the disease outbreaks, disasters and humanitarian crises where WHO plays an essential role in supporting countries to respond to and recover from emergencies with public health consequences.”

Crisis in Tigray, Ethiopia
:: Ethiopia – Tigray Region Humanitarian Update Situation Report Last updated: 9 Jul 2021

 

Ebola outbreak, Democratic Republic of the Congo, 2021
[Last apparent update: 3 May 2021]

Ebola outbreak outbreak, N’Zerekore, Guinea, 2021 [Last apparent update: 3 May 2021]

Coronavirus disease (COVID-19) pandemic [Last apparent update 16 July 2021; See COVID above]

Ebola outbreak, Equateur Province, Democratic Republic of the Congo, 2020 [Last apparent update: 1 June 2021]

Ebola outbreak, North Kivu, Ituri, Democratic Republic of the Congo, 2018 – 2020 [Last apparent update: 3 May 2021]

Ebola outbreak, Democratic Republic of the Congo, 2018 [Last apparent update: 24 July 2018]

Yemen crisis [Last apparent update: 12 February 2021]

Syria crisis [Last apparent update: 18 June 2021]

Somalia crisis [Last apparent update: 24 March 2018]

Nigeria crisis [Last apparent update: 9 May 2018]

Ebola outbreak, Democratic Republic of the Congo, 2017 [Last apparent update: 3 May 2021]

Zika virus disease outbreak, 2015-2016 [Last apparent update: 24 Jan 2020]

Ebola outbreak: West Africa, 2014-2016 [Last apparent update: 3 May 2021]

Iraq crisis [Last apparent update: 9 Jan 2008]

South Sudan crisis [Last apparent update: 23 Sep 2020]

Avian influenza A (H7N9) virus outbreak [Last apparent update: 21 May 2021]

Middle East respiratory syndrome (MERS-CoV) outbreak [Last apparent update: 8 July 2019]

Influenza A (H1N1) virus, 2009-2010 pandemic [Last apparent update: 10 Aug 2010]

 

::::::

UN OCHA – Current Emergencies
Current Corporate Emergencies
Northern Ethiopia
Ethiopia – Tigray Region Humanitarian Update Situation Report, 19 July 2021
HIGHLIGHTS
:: Over eight months on since the start of the conflict in Tigray, the humanitarian situation remains alarmingly dire and could further deteriorate if immediate action is not taken.
:: Inside the region, humanitarians can now access previously hard-to-reach area, with 75 per cent of the population now in zones where relief operations can take place.
:: In addition, a humanitarian convoy arrived on 12 July in Tigray’s capital Mekelle, the first to reach the region in more than two weeks.
:: However, supplies & personnel fall short of the immense needs of people in Tigray. Stocks are depleting fast, as road access to the region has been curtailed over the last weeks.
:: Increased humanitarian funding and unfettered access to the region is urgently needed to prevent loss of life in Tigray

 

::::::
::::::

WHO & Regional Offices [to 24 Jul 2021]

WHO & Regional Offices [to 24 Jul 2021]

23 July 2021 Departmental news
First World #DrowningPrevention Day calls for accelerated action to prevent drowning, offers strategies to save lives

23 July 2021 Departmental news
Governments commit to accelerate action to improve access to eye care services

23 July 2021 Statement
Together to #ENDviolence: Leaders’ Statement. Six game-changing actions to End Violence Against Children

22 July 2021 Joint News Release
Vaccine inequity undermining global economic recovery

22 July 2021 Joint News Release
International Paralympic Committee, World Health Organization sign memorandum of understanding to cooperate in the promotion of diversity and equity in health and sports

21 July 2021 Joint News Release
New report reveals stark inequalities in access to HIV prevention and treatment services for children—partners call for urgent action

20 July 2021 Departmental news
Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study

19 July 2021 Departmental news
Persons with disabilities tell their stories

19 July 2021 Departmental news
WHO Position Statement on Innovative Clinical Trial Designs for Development of New TB Treatments

19 July 2021 Joint News Release
WFP and WHO launch innovative project on Emergency Health Facilities

::::::

 

WHO Regional Offices
Selected Press Releases, Announcements
WHO African Region AFRO
No new digest content identified

WHO Region of the Americas PAHO
No new digest content identified

WHO South-East Asia Region SEARO
No new digest content identified

WHO European Region EURO
:: Summit on COVID-19 impacts on mental health 23-07-2021
:: SARS-CoV-2 Delta variant now dominant in much of European region; efforts must be reinforced to prevent transmission, warns WHO Regional Office for Europe and ECDC 23-07-2021
:: Supporting Uzbekistan throughout the COVID-19 pandemic 22-07-2021

WHO Eastern Mediterranean Region EMRO
No new digest content identified

WHO Western Pacific Region
No new digest content identified

 

::::::

New WHO Publications [Selected]
https://www.who.int/publications/i
23 July 2021
Guidance on conducting vaccine effectiveness evaluations in the setting of new SARS-CoV-2 variants: Interim guidance, 22 July 2021. Addendum to Evaluation of COVID-19 vaccine effectiveness

19 July 2021
Global technical strategy for malaria 2016-2030, 2021 update

MMWR News Synopsis Friday, July 23, 2021

MMWR News Synopsis Friday, July 23, 2021
:: Changes in Influenza and Other Respiratory Viral Activity During the COVID-19 Pandemic — United States, 2020–2021
In 2020, most of these viruses circulated at historically low levels, likely because of widespread use of COVID-19 prevention measures, including limited global travel, mask use,  physical distancing, and staying home. However, some of these viruses, such as RSV, have begun circulating at increased levels at an unusual time of the year…

China CDC

China CDC http://www.chinacdc.cn/en/

National Health Commission of the People’s Republic of China [to 24 Jul 2021]
http://en.nhc.gov.cn/
News
July 24: Daily briefing on novel coronavirus cases in China
On July 23, 31 provincial-level regions and the Xinjiang Production and Construction Corps on the Chinese mainland reported 35 new cases of confirmed infections

China urges tracing COVID-19 origin in multiple countries
2021-07-23

China provides over 600m COVID-19 vaccine doses to countries around world
2021-07-23

‘Lab leak’ theory unfounded
2021-07-23

National Medical Products Administration – PRC [to 24 Jul 2021]
http://english.nmpa.gov.cn/news.html
News
Over 1.49 bln doses of COVID-19 vaccines administered in China
2021-07-23
Over 1.49 billion doses of COVID-19 vaccines have been administered in China as of Wednesday, the National Health Commission announced on July 22.

CCDC Weekly – Weekly Reports: Current Volume (3)
2021-07-23 / No. 30
PDF of this issue
:: Outbreak Reports: Long Distance Transmission of SARS-CoV-2 from Contaminated Cold Chain Products to Humans — Qingdao City, Shandong Province, China, September 2020
:: Preplanned Studies: Belief in Science and Attitudes Toward COVID-19: A Demographic Standardization Approach to China–US Comparison, 2020
:: Notes from the Field: An Imported Confirmed Case of COVID-19 Vaccinated in Brazil — Shanghai Municipality, China, March 17, 2021
:: Notes from the Field: Detection of Variants of B.1.617 Lineage from Five Returning Chinese Nationals at a Guangxi-Vietnam Border Port — Guangxi Zhuang Autonomous Region, China, April 2021

Organization Announcements

Organization Announcements
Editor’s Note:
Careful readers will note that the number and range of organizations now monitored in our Announcements section below has grown as the impacts of the pandemic have spread across global economies, supply chains and programmatic activity of multilateral agencies and INGOs.

 

Paul G. Allen Frontiers Group [to 24 Jul 2021]
https://alleninstitute.org/what-we-do/frontiers-group/news-press/
News
No new digest content identified.

 

BARDA – U.S. Department of HHS [to 24 Jul 2021]
https://www.phe.gov/about/barda/Pages/default.aspx
News
No new digest content identified.

 

BMGF – Gates Foundation [to 24 Jul 2021]
https://www.gatesfoundation.org/ideas/media-center
Press Releases and Statements
No new digest content identified.

 

Bill & Melinda Gates Medical Research Institute [to 24 Jul 2021]
https://www.gatesmri.org/
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.

 

CARB-X [to 24 Jul 2021]
https://carb-x.org/
News
No new digest content identified.

 

Center for Vaccine Ethics and Policy – GE2P2 Global Foundation [to 24 Jul 2021]
https://centerforvaccineethicsandpolicy.net/
News/Analysis/Statements
:: Past weekly editions and posting of all segments of Vaccines and Global Health: The Week in Review are available here.
:: [NEW] Informed Consent: A Monthly Review – July 2021 is now posted here

 

CEPI – Coalition for Epidemic Preparedness Innovations [to 24 Jul 2021]
http://cepi.net/
Latest News
CEPI partners with Shanghai Zerun Biotech to develop COVID-19 variant vaccine
CEPI will provide US$13.1 million to advance development of both COVID-19 prototype and variant vaccine candidates.
COVAX 21 Jul 2021

CEPI and IVI collaborate on clinical research to expand access to COVID-19 vaccines in Africa
New programme of clinical research in Mozambique aims to support the expanded use of the BBIBP-CorV vaccine in Africa.
COVID-19 20 Jul 2021

 

CIOMS – COUNCIL FOR INTERNATIONAL ORGANIZATIONS OF MEDICAL SCIENCES [to 24 Jul 2021]
https://cioms.ch/
News; Publications
No new digest content identified.

 

DARPA – Defense Advanced Research Projects Agency [to 24 Jul 2021
https://www.darpa.mil/news
News
No new digest content identified.

 

Duke Global Health Innovation Center [to 24 Jul 2021]
https://dukeghic.org/
How can LMIC countries prepare to receive and efficiently administer large numbers of COVID-19 vaccine doses?
Melissa Slogan July 16, 2021

 

EDCTP [to 24 Jul 2021]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
No new digest content identified.

 

Emory Vaccine Center [to 24 Jul 2021]
http://www.vaccines.emory.edu/
Vaccine Center News
No new digest content identified.

 

European Vaccine Initiative [to 24 Jul 2021]
http://www.euvaccine.eu/
Latest News
No new digest content identified

 

FDA [to 24 Jul 2021]
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/default.htm
Press Announcements
July 23, 2021 – Coronavirus (COVID-19) Update: July 23, 2021
:: A new FDA Voices, Global Regulators Envision Paradigm Shift Toward Inclusion of Pregnant and Breastfeeding Women in Clinical Research for Medicines and Vaccines, describes efforts being made to address inadequacies in research through a paradigm shift in the approach to studying medical products in pregnant and breastfeeding women.

July 20, 2021 – Coronavirus (COVID-19) Update: July 20, 2021
:: This week, at the FDA SBIA REdI Annual Conference, FDA leaders reflected on the FDA’s use of Emergency Use Authorizations (EUAs) and other resources in making drug, device and biological products available to support the public health response to the COVID-19 pandemic. Day 1External Link Disclaimer and Day 2External Link Disclaimer recordings are now available on YouTube. The conference c
ontinues through Friday, with additional sessionsExternal Link Disclaimer on devices and biologics.
:: Last week, the FDA held a stakeholder call to discuss COVID-19 vaccines, including preliminary reports of Guillain-Barré Syndrome following Janssen COVID-19 vaccination. HereExternal Link Disclaimer is an excerpt from that call where Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research discussed the importance of getting vaccinated.
:: An FDA Consumer Update, Learn More About COVID-19 Vaccines From the FDA, is now available in five additional languages: Spanish, Chinese, Korean, Tagalog, and Vietnamese. See the evidence for each COVID-19 vaccine and the reasoning behind the FDA’s Emergency Use Authorizations (EUAs).

 

Fondation Merieux [to 24 Jul 2021]
http://www.fondation-merieux.org/
News, Events
No new digest content identified.

 

Gavi [to 24 Jul 2021]
https://www.gavi.org/
News Releases
23 July 2021
First doses donated by Japan to COVAX reach lower-income countries

 

GHIT Fund [to 24 Jul 2021]
https://www.ghitfund.org/newsroom/press
GHIT was set up in 212 with the aim of developing new tools to tackle infectious diseases that
No new digest content identified.

 

Global Fund [to 24 Jul 2021]
https://www.theglobalfund.org/en/news/
News & Stories
No new digest content identified.

 

Global Research Collaboration for Infectious Disease Preparedness [GloPID-R] [to 24 Jul 2021]
https://www.glopid-r.org/news/
News
No new digest content identified.

 

Hilleman Laboratories [to 24 Jul 2021]
http://www.hillemanlabs.org/
Website reports “under maintenance” at inquiry

 

Human Vaccines Project [to 24 Jul 2021]
http://www.humanvaccinesproject.org/
News
News webpage not responding at inquiry

 

IAVI [to 24 Jul 2021]
https://www.iavi.org/newsroom
Latest News
No new digest content identified.

 

 

International Coalition of Medicines Regulatory Authorities [ICMRA]
http://www.icmra.info/drupal/en/news
Selected Statements, Press Releases, Research
No new digest content identified.

 

ICRC [to 24 Jul 2021]
https://www.icrc.org/en/whats-new
Selected News Releases, Statements, Reports
Afghanistan: Civilians paying steep price of surge in violence and COVID-19
ICRC activities in Afghanistan, one of the the deadliest places in the world to be a civilian, and women and children make up nearly half of all civilian casualties.
21-07-2021 | News release

 

 

International Generic and Biosimilar Medicines Association [IGBA]
https://www.igbamedicines.org/
News
No new digest content identified.

 

 

IFFIm
http://www.iffim.org/
Press Releases/Announcements
No new digest content identified.

 

IFRC [to 24 Jul 2021]
http://media.ifrc.org/ifrc/news/press-releases/
Selected Press Releases, Announcements
No new digest content identified.

 

Institut Pasteur [to 24 Jul 2021]
https://www.pasteur.fr/en/press-area
Press Documents
Press release 16.07.2021
ComCor study: analysis of the effectiveness of messenger RNA vaccines against the SARS-CoV-2 Alpha and Beta variants in France
Over the past six months, the World Health Organization has categorized four SARS-CoV-2 variants as being “of concern”…

 

IOM / International Organization for Migration [to 24 Jul 2021]
http://www.iom.int/press-room/press-releases
News
No new digest content identified.

 

IRC International Rescue Committee [to 24 Jul 2021]
http://www.rescue.org/press-release-index
Media highlights [Selected]
No new digest content identified.

 

IVAC [to 24 Jul 2021]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
Updates; Events
Webinar: Preventing the Next Pandemic: Vaccine Diplomacy, Surveillance and COVID Vaccines
When: Jul 30, 2021 at 11:00 AM Eastern Time
Description: Join Dr. Peter Hotez for a 60-minute webinar hosted by the International Vaccine Access Center to discuss topics ranging from vaccine diplomacy, the antivaccine movement, safety surveillance, and a new COVID vaccine.

 

IVI [to 24 Jul 2021]
http://www.ivi.int/
Selected IVI News, Announcements, Events
CEPI and IVI collaborate on clinical research to expand access to COVID-19 vaccines in Africa
July 20, 2021; Oslo, Norway and Seoul, Republic of Korea: The Coalition for Epidemic Preparedness Innovations (CEPI) and the International Vaccine Institute (IVI) today announced a new programme of clinical research which aims to expand access to COVID-19 vaccines in Africa. CEPI will provide funding of up to $12.7m to the Expanding Access and Delivery of COVID-19 Vaccines in Africa (ECOVA) consortium led by IVI to carry out clinical trials of Sinopharm’s BBIBP-CorV vaccine which will support the expanded use of the vaccine on the African continent.
Up to 170 million doses of BBIBP-CorV will be distributed by the COVAX Facility under an agreement announced on 12 July 2021, and the vaccine is already being deployed in over 50 countries around the world. However there have been no clinical trials of BBIBP-CorV in African populations or against the variants of concern circulating in southern Africa. The ECOVA research programme aims to generate crucial data to inform the use of the vaccine in Africa, and potentially expand use of the vaccine to HIV-infected individuals. All results generated by ECOVA will be made available open source to inform policy makers and regulatory authorities’ recommendations on the use of BBIBP-CorV in national immunization programmes…
The ECOVA consortium is led by IVI, working in partnership with Mozambique’s Instituto Nacional de Saúde (INS), the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), the University of Heidelberg, Germany (UH), Harvard University, USA, and the University of Antananarivo in Madagascar (UA)…

 

JEE Alliance [to 24 Jul 2021]
https://www.jeealliance.org/
Selected News and Events
No new digest content identified.

 

Johns Hopkins Center for Health Security [to 24 Jul 2021]
https://www.centerforhealthsecurity.org/news/center-news/
Center News
No new digest content identified.

 

MSF/Médecins Sans Frontières [to 24 Jul 2021]
http://www.msf.org/
Latest [Selected Announcements]
South Africa
Supporting overstretched health centres and vulnerable communities in the aftermath of the violence
Project Update 23 Jul 2021

Mediterranean migration
MSF requests the revocation of the Geo Barents’ detention
Open Letter 23 Jul 2021

Central African Republic
Repeated attacks on medical care leave people vulnerable to disease and death
Press Release 19 Jul 2021

 

National Academy of Medicine – USA [to 24 Jul 2021]
https://nam.edu/programs/
Selected News/Programs
Discussion Paper Offers Guidance on Identifying Credible Sources of Health Information in Social Media
July 21, 2021
WASHINGTON — A new individually authored discussion paper in NAM Perspectives — the digital periodical of the National Academy of Medicine — outlines principles and attributes that social media platforms can use to identify potentially credible sources of health information online.

 

National Academy of Sciences – USA [to 24 Jul 2021]
http://www.nasonline.org/news-and-multimedia/
News
As Surgeon General Urges ‘Whole-of-Society’ Effort to Fight Health Misinformation the Work of the National Academies Helps Foster an Evidence-Based Information Environment
July 14, 2021
The U.S. surgeon general has released a public advisory calling misinformation a ‘serious threat to public health.’ The National Academies have been addressing misinformation in health and science on multiple fronts and are taking steps to help cultivate a fact- and evidence-based information environment.

 

National Vaccine Program Office – U.S. HHS [to 24 Jul 2021]
https://www.hhs.gov/vaccines/about/index.html
Upcoming Meetings/Latest Updates
No new digest content identified.

 

NIH [to 24 Jul 2021]
http://www.nih.gov/news-events/news-releases
News Releases
Tuesday, July 20, 2021
More than 1.5 million children lost a primary or secondary caregiver due to the COVID-19 pandemic
Addressing the impact of caregiver deaths critical for pediatric mental health, authors note.

 

PATH [to 24 Jul 2021]
https://www.path.org/media-center/
Press Releases
No new digest content identified.

 

Sabin Vaccine Institute [to 24 Jul 2021]
http://www.sabin.org/updates/pressreleases
Statements and Press Releases
No new digest content identified.

 

UNAIDS [to 24 Jul 2021]
http://www.unaids.org/en
Selected Press Releases/Reports/Statements
23 July 2021
2021 ECOSOC resolution on the Joint Programme adopted by consensus

22 July 2021
UNAIDS saddened by the death of Cyriaque Yapo Ako

22 July 2021
Changing the landscape of community engagement in the HIV response in Indonesia

21 July 2021
An HIV vaccine: who needs it?

21 July 2021
2025 AIDS targets: the next generation of goals for the global AIDS response

19 July 2021
Opening session of the IAS Conference on HIV Science

19 July 2021
KFF/UNAIDS analysis finds that while donor government spending on HIV increased in 2020, future funding is uncertain with COVID-19 challenges

 

UNHCR Office of the United Nations High Commissioner for Refugees [to 24 Jul 2021]
http://www.unhcr.org/en-us/media-centre.htmlS
Selected News Releases, Announcements
Record numbers forced to flee ongoing violence in Burkina Faso
23 Jul 2021

UNICEF [to 24 Jul 2021]
https://www.unicef.org/media/press-releases
Press Releases, News Notes, Statements [Selected]
Statement 07/19/2021
Statement by UNICEF Executive Director Henrietta Fore on children deprived of parental care due to COVID-19
NEW YORK, 19 July 2021 – “As the official COVID-19 death toll around the world passed 4 million earlier this month, UNICEF is increasingly concerned for children left without one or both parents.
“As with all crises and health pandemics, the most vulnerable children are at increased risk of losing parental care – due to death, severe illness or financial hardship. This in turn increases their risk of being placed in unsuitable alternative care.
“While it’s too early to estimate the number of children orphaned or abandoned as a result of the pandemic, a spike in deaths in some countries means many children already vulnerable to the impacts of COVID-19 face further emotional distress and protection concerns…

 

Unitaid [to 24 Jul 2021]
https://unitaid.org/
Featured News
No new digest content identified.

Vaccine Equity Initiative [to 24 Jul 2021]
https://vaccineequitycooperative.org/news/
News
No new digest content identified.

 

Vaccination Acceptance & Demand Initiative [Sabin) [to 24 Jul 2021]
https://www.vaccineacceptance.org/
Announcements
No new digest content identified.

 

Vaccine Confidence Project [to 24 Jul 2021]
http://www.vaccineconfidence.org/
News, Research and Reports
Coronavirus global impact
Launched April 2, 2020 and recurring every 3 days, Premise Data is utilizing its global network of Contributors to assess economic, social, and health sentiment surrounding the coronavirus (COVID-19).

 

Vaccine Education Center – Children’s Hospital of Philadelphia [to 24 Jul 2021]
http://www.chop.edu/centers-programs/vaccine-education-center
News
No new digest content identified.

 

Wellcome Trust [to 24 Jul 2021]
https://wellcome.ac.uk/news
News and reports
No new digest content identified.

 

The Wistar Institute [to 24 Jul 2021]
https://www.wistar.org/news/press-releases
Press Releases
Jul. 20, 2021
Wistar Scientists Discovered Fundamental and Widespread Gene Expression Control Mechanism that Potentially Creates Proteins at Distinct Locations in the Cell, with Implications in Immunity and Cancers
Through alternative polyadenylation, RNA molecules are directed to sites of protein synthesis to facilitate production of certain proteins where they are most needed.

 

WFPHA: World Federation of Public Health Associations [to 24 Jul 2021]
https://www.wfpha.org/
Latest News
No new digest content identified.

 

World Bank [to 24 Jul 2021]
http://www.worldbank.org/en/news/all
Selected News, Announcements
World Bank Group’s $157 Billion Pandemic Surge Is Largest Crisis Response in Its History
In response to COVID-19 severely damaging the lives and livelihoods of millions of people in developing countries, the World Bank Group deployed over $157 billion to fight the pandemic’s health, economic, and social impacts over the last 15 months (April 1, 2020 – June 30, 2021). This is the largest crisis response of any such period in the Bank Group’s history and represents an increase of more than 60% over the 15-month period prior to the pandemic. Bank Group commitments and mobilizations in fiscal year 2021 (FY21) alone (July 1, 2020 – June 30, 2021) amounted to almost $110 billion (or $84 billion excluding mobilization, short-term financing, and recipient-executed trust funds).
Since the start of the pandemic, the Bank Group supported countries to address the health emergency, strengthen health systems, protect the poor and vulnerable, support businesses, create jobs and jump start a green, resilient, and inclusive recovery.
Following last year’s COVID-related economic deterioration, the global economy is expected to expand 5.6% in 2021. Thus far, the recovery is uneven and many of the world’s poorest countries are being left behind. While about 90% of advanced economies are expected to regain their pre-pandemic per capita income levels by 2022, only about one-third of emerging market and developing economies are projected to do the same. In 2020, global extreme poverty rose for the first time in over 20 years, with nearly 100 million people pushed into extreme poverty.
Date: July 19, 2021 Type: Press Release

Health Emergency Preparedness and Response (HEPR) Umbrella Program
Supporting better health emergency preparedness and more effective responses
Given the urgency for stronger global health security and the need to help developing countries get better prepared for disease outbreaks, the World Bank Group established the new Health Emergency Preparedness and Response (HEPR) Umbrella Program to support eligible countries and territories to improve their capacities to prepare for, prevent, respond and mitigate the impact of epidemics on people.
The HEPR Umbrella Program provides financing to low-income countries and to countries with low health emergency preparedness and response capabilities. The program was set up earlier this year to support low-income countries and countries with struggling health emergency responses in building resilience and increasing investments in health preparedness – including their immediate COVID-19 response. It is an important tool in the World Bank’s pandemic response and longer-term health preparedness in countries that need support and their most vulnerable communities, including refugees.
Financial support is also available for countries that are unable to access regular for World Bank financing because they are in arrears with their payments to the International Development Association (IDA), and to Jordan and Lebanon for supporting Syrian refugees. Looking ahead, the program seeks to support more countries to meet critical needs.
Date: July 19, 2021 Type: Brief

 

World Customs Organization – WCO [to 24 Jul 2021]
http://www.wcoomd.org/
Latest News – Selected Items
23 July 2021
The role of Customs presented in a WHO-WTO High-Level Dialogue on expanding COVID-19 vaccine manufacturing

20 July 2021
The WCO Environment Programme engages with 11 Customs administrations in the field of illegal wildlife trade

 

World Organisation for Animal Health (OIE) [to 24 Jul 2021]
https://www.oie.int/en/for-the-media/press-releases/2021/
Press Releases, Statements
Editorial
Responding to emergencies through preparedness and resilience
19 July 2021
The COVID-19 pandemic has impacted almost all walks of life and it has required a multisectoral and interdisciplinary approach to respond to this global emergency.
Monique Éloit, Director General, World Organisation for Animal Health (OIE)

 

WTO – World Trade Organisation [to 24 Jul 2021]
http://www.wto.org/english/news_e/news_e.htm
WTO News and Events
WHO-WTO dialogue steps up efforts for increased COVID-19 vaccine production and equitable access
21 July 2021
The World Health Organization (WHO) and the WTO on 21 July hosted a High-Level Dialogue on “Expanding COVID-19 vaccine manufacture to promote equitable access”, with the participation of senior policymakers, heads of multilateral agencies, vaccine manufacturers, development finance institutions, global health initiatives and public health activists.

High-Level Dialogue on “Expanding COVID-19 vaccine manufacture to promote equitable access”
21 July 2021
Remarks by DG Okonjo-Iweala

TRIPS Council agrees to continue discussions on IP response to COVID-19
20 July 2021
At a meeting of the Council for Trade-Related Aspects of Intellectual Property Rights (TRIPS) on 20 July 2021, WTO members agreed to continue consideration of the proposal for a temporary waiver of certain TRIPS obligations in response to COVID-19 and other related proposals. Members approved a status report which they tasked the chair to deliver at the General Council at its next meeting on 27-28 July.

WTO publishes list of bottlenecks and facilitating measures on critical COVID-19 products
20 July 2021
The WTO Secretariat has issued an indicative list of trade-related bottlenecks and trade-facilitating measures on critical products to combat COVID-19, including inputs used in vaccine manufacturing, vaccine distribution and approval, therapeutics and pharmaceuticals, diagnostics and medical devices. The list is being released in advance of a High-Level Dialogue by the World Health Organization (WHO) and the WTO on 21 July on expanding COVID-19 vaccines manufacturing to promote equitable access.

::::::

 

ARM [Alliance for Regenerative Medicine] [to 24 Jul 2021]
Press Releases – Alliance for Regenerative Medicine (alliancerm.org)
Selected Press Releases
No new digest content identified.

 

BIO [to 24 Jul 2021]
https://www.bio.org/press-releases
Press Releases, Letters, Testimony, Comments [Selected]
No new digest content identified.

 

DCVMN – Developing Country Vaccine Manufacturers Network [to 24 Jul 2021]
http://www.dcvmn.org/
News; Upcoming events
No new digest content identified.

 

ICBA – International Council of Biotechnology Associations [to 24 Jul 2021]
https://internationalbiotech.org/news/
News
No new digest content identified.

 

IFPMA [to 24 Jul 2021]
http://www.ifpma.org/resources/news-releases/
Selected Press Releases, Statements, Publications
IFPMA Statement at WTO-WHO High Level Dialogue “Expanding COVID-19 Vaccine Manufacture to Promote Equitable Access”
21 July 2021
[See COVID above for detail]

 

International Alliance of Patients’ Organizations – IAPO [to 24 Jul 2021]
https://www.iapo.org.uk/news/topic/6
Press and media [Selected]
Patient empowerment can unlock the benefits of self-care
Thursday, 22 July 2021
Self-care activities are an essential component of patient-centered health care systems. The World Health Organization defines self-care as “the ability of individuals, families, and communities to promote health, prevent disease, maintain health, and to cope with illness and disability with or without the support of a healthcare provider.”

 

PhRMA [to 24 Jul 2021]
http://www.phrma.org/
Latest News [Selected]
Dose sharing as a part of the COVID-19 global vaccine equity strategy
July 20, 2021
Dose sharing is one of the strategies helping to accelerate work to broaden global access to COVID-19 vaccines…
…With millions of doses either shared or making their way to nations in need, we are already seeing the benefits of dose sharing as a strategy to promote COVID-19 vaccine equity. Leaders should focus on this and other meaningful solutions to ensure more shots are administered to more people.
Rather than pursuing misguided proposals to waive international commitments to protect intellectual property (IP) for COVID-19 innovations, industry supports practical strategies like dose sharing that better serve low- and middle-income nations while also upholding the IP ecosystem that made COVID-19 innovation possible.
Blog Post

Journal Watch

Journal Watch
Vaccines and Global Health: The Week in Review continues its weekly scanning of key peer-reviewed journals to identify and cite articles, commentary and editorials, books reviews and other content supporting our focu-s on vaccine ethics and policy. Journal Watch is not intended to be exhaustive, but indicative of themes and issues the Center is actively tracking. We selectively provide full text of some editorial and comment articles that are specifically relevant to our work. Successful access to some of the links provided may require subscription or other access arrangement unique to the publisher.
If you would like to suggest other journal titles to include in this service, please contact David Curry at: david.r.curry@centerforvaccineethicsandpolicy.org

Spatial Inequities in COVID-19 Testing, Positivity, Confirmed Cases, and Mortality in 3 U.S. Cities

Annals of Internal Medicine
July 2021 Volume 174, Issue 7
http://annals.org/aim/issue

 

Original Research
Spatial Inequities in COVID-19 Testing, Positivity, Confirmed Cases, and Mortality in 3 U.S. Cities
An Ecological Study
FREE
Usama Bilal, PhD, Loni P. Tabb, PhD, Sharrelle Barber, ScD, Ana V. Diez Roux, PhD Pages:936–944

Health Information Privacy, Protection, and Use in the Expanding Digital Health Ecosystem: A Position Paper of the American College of Physicians

Annals of Internal Medicine
July 2021 Volume 174, Issue 7
http://annals.org/aim/issue

 

Position Papers
Health Information Privacy, Protection, and Use in the Expanding Digital Health Ecosystem: A Position Paper of the American College of Physicians
FREE
Brooke Rockwern, MPH, Dejaih Johnson, JD, MPA, Lois Snyder Sulmasy, JD,
Pages:994–998
Abstract
Technologic advancements and the evolving digital health landscape have offered innovative solutions to several of our health care system’s issues as well as increased the number of digital interactions and type of personal health information that is generated and collected, both within and outside of traditional health care. This American College of Physicians’ position paper discusses the state of privacy legislation and regulations, highlights existing gaps in health information privacy protections, and outlines policy principles and recommendations for the development of health information privacy and security protections that are comprehensive, transparent, understandable, adaptable, and enforceable. The principles and recommendations aim to improve on the privacy framework in which physicians have practiced for decades and expand similar privacy guardrails to entities not currently governed by privacy laws and regulations. The expanded privacy framework should protect personal health information from unauthorized, discriminatory, deceptive, or harmful uses and align with the principles of medical ethics, respect individual rights, and support the culture of trust necessary to maintain and improve care delivery.

Toward Understanding COVID-19 Recovery: National Institutes of Health Workshop on Postacute COVID-19

Annals of Internal Medicine
July 2021 Volume 174, Issue 7
http://annals.org/aim/issue

 

Special Articles
Toward Understanding COVID-19 Recovery: National Institutes of Health Workshop on Postacute COVID-19
FREEAndrea M. Lerner, MD, Daphne A. Robinson, PhD, Linda Yang, PhD, Carolyn F. Williams, PhD, MPH, … et al.
Pages:999–1003

Gurus and Griots: Revisiting the research informed consent process in rural African contexts

BMC Medical Ethics
http://www.biomedcentral.com/bmcmedethics/content
(Accessed 24 Jul 2021)

 

Gurus and Griots: Revisiting the research informed consent process in rural African contexts
Researchers conducting community-based participatory action research (CBPAR) in highly collectivistic and socioeconomically disadvantaged community settings in sub-Saharan Africa are confronted with the distinctive challenge of balancing universal ethical standards with local standards, where traditional customs or beliefs may conflict with regulatory requirements and ethical guidelines underlying the informed consent (IC) process. The unique ethnic, socioeconomic, and cultural diversities in these settings have important implications for the IC process, such as individual decisional autonomy, beneficence, confidentiality, and signing the IC document.
Authors: Richard Appiah
Citation: BMC Medical Ethics 2021 22:98
Content type: Debate
Published on: 23 July 2021

E-health roadmap for COVID-19 vaccine coverage in Iran

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 24 Jul 2021)

 

E-health roadmap for COVID-19 vaccine coverage in Iran
Vaccination is the effective and long-term pharmacological solution to deal with COVID-19. Information technology (IT) and electronic immunization can be effective in accelerating and improving vaccine coverag…
Authors: Elham Maserat, Leila Keikha, Somayeh Davoodi and Zeinab Mohammadzadeh
Citation: BMC Public Health 2021 21:1450
Content type: Research
Published on: 23 July 2021

Beliefs and barriers associated with COVID-19 vaccination among the general population in Saudi Arabia

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 24 Jul 2021)

 

Beliefs and barriers associated with COVID-19 vaccination among the general population in Saudi Arabia
Developing a vaccine against COVID-19 is considered a key strategy to end the pandemic. However, public acceptance is reliant on beliefs and perception toward the vaccine. Therefore, the study aimed to assess …
Authors: Rania M. Magadmi and Fatemah O. Kamel
Citation: BMC Public Health 2021 21:1438
Content type: Research article
Published on: 21 July 2021

Effectiveness of participant recruitment strategies for critical care trials: A systematic review and narrative synthesis

Clinical Trials

Volume 18 Issue 4, August 2021

https://journals.sagepub.com/toc/ctja/18/4

 

Recruitment and Retention
Effectiveness of participant recruitment strategies for critical care trials: A systematic review and narrative synthesis
Timia Raven-Gregg, Fiona Wood, Victoria Shepherd
First Published February 2, 2021; pp. 436–448

Supplement: E-Mental-Health: Exploring the Evidence Base and Stakeholders’ Perspectives on Internet-Based Interventions for the Prevention of Mental Health Conditions

The European Journal of Public Health
SUPPLEMENT – Volume 31, Issue Supplement_1, July 2021
https://academic.oup.com/eurpub/issue/31/Supplement_1

 

Supplement: E-Mental-Health: Exploring the Evidence Base and Stakeholders’ Perspectives on Internet-Based Interventions for the Prevention of Mental Health Conditions
Mental illness represents an enormous personal, social and societal burden for European citizens1 calling for the need to expand existing models of mental healthcare delivery. In Europe, the Internet is a key source of health information,2 and technology-enhanced (psychological) interventions such as Internet- and mobile-delivered applications (‘eHealth’3 and ‘m-Health’4) have become increasingly popular and studied. There is already strong evidence of the efficacy of online interventions for the prevention and treatment of several psychological disorders5,6 and meta-analyses show effect sizes similar to face-to-face interventions.7

Conflict and COVID-19 in Yemen: beyond the humanitarian crisis

Globalization and Health
http://www.globalizationandhealth.com/
[Accessed 24 Jul 2021]

 

Conflict and COVID-19 in Yemen: beyond the humanitarian crisis
Yemen has been left in shambles and almost destroyed by its devastating civil war, and is now having to deal with the spread of coronavirus. The Yemeni people have been are left to fend for themselves and face…
Authors: Mohammed Alsabri, Ayman Alhadheri, Luai M. Alsakkaf and Jennifer Cole
Citation: Globalization and Health 2021 17:83
Content type: Commentary
Published on: 22 July 2021

July 2021 | Borders, Immigrants & Health

Health Affairs
Vol. 40, No. 7 July 2021
https://www.healthaffairs.org/toc/hlthaff/current

 

July 2021 | Borders, Immigrants & Health
About one in seven residents of the US is an immigrant, and about fifteen million people live within 100 kilometers of the US-Mexico border. Disparities in health status exist between people born in the US and those who have immigrated. Immigration policy has been contentious throughout US history, and current policies in the US and Mexico have significant effects on the health and well-being of tens of millions of people. This thematic issue of Health Affairs focuses on immigrants and borders. The overview article by Arturo Vargas Bustamante and coauthors describes a range of health policy issues raised by the continuously shifting demography of US immigrants.

Rethinking approaches of science, technology, and innovation in healthcare during the COVID-19 pandemic: the challenge of translating knowledge infrastructures to public needs

Health Research Policy and Systems
http://www.health-policy-systems.com/content
[Accessed 24 Jul 2021]

 

Rethinking approaches of science, technology, and innovation in healthcare during the COVID-19 pandemic: the challenge of translating knowledge infrastructures to public needs
Authors: Renan Gonçalves Leonel da Silva, Roger Chammas and Hillegonda Maria Dutilh Novaes
Content type: Commentary
21 July 2021
Introduction
The coronavirus 2019 (COVID-19) pandemic has changed how we understand and approach problems in science, technology, and innovation (ST&I) in health in contemporary society. The current situation has produced specific demands for health systems, and an inconvenient paradox has become visible: we have never had such a supply of qualified scientific and technological knowledge infrastructures in health and biomedical sciences, but at the same time a viable translation of this knowledge to public health systems has shown itself flawed and inefficient. This paradox raises questions about what has brought us to this inconvenient reality, and the importance of paying greater attention to the mechanisms of governance and implementation of ST&I in public health in a more systemic way.

Localisation and local humanitarian action

Humanitarian Exchange Magazine
Number 79, May 2021
https://odihpn.org/magazine/inclusion-of-persons-with-disabilities-in-humanitarian-action-what-now/

 

Localisation and local humanitarian action
by HPN October 2020
The theme of this edition of Humanitarian Exchange is localisation+ and local humanitarian action. Five years ago this week, donors, United Nations (UN) agencies,  non-governmental organisations (NGOs), the International Committee of the Red Cross (ICRC) and International Federation of Red Cross and Red Crescent Societies (IFRC) committed within the Grand Bargain to increase multi-year investments in the institutional capacities of local and national responders, and to provide at least 25% of humanitarian funding to them as directly as possible. Since then, there is increasing consensus at policy and normative level, underscored by the Covid-19 pandemic, that local leadership should be supported.  Localisation has gone from a fringe conversation among policy-makers and aid agencies in 2016 to a formal priority under the Grand Bargain. Wider global movements on anti-racism and decolonisation have also brought new momentum to critical reflections on where power, knowledge and capacity reside in the humanitarian system. Yet progress has been slow and major gaps remain between the rhetoric around humanitarian partnerships, funding and coordination and practices on the ground.

Multi-level determinants of failure to receive timely and complete measles vaccinations in Southwest China: a mixed methods study

Infectious Diseases of Poverty
http://www.idpjournal.com/content
[Accessed 24 Jul 2021]

 

Multi-level determinants of failure to receive timely and complete measles vaccinations in Southwest China: a mixed methods study
Authors: Xian-Yan Tang, Man Cheng, Alan Geater, Qiu-Yun Deng, Ge Zhong, Yue-Dong Lin, Ning Chen, Tao Lan, Long-Yan Jiang, Man-Tong Zhu and Qiao Li
Content type: Research Article
22 July 2021

Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating CircumstancesThe CONSERVE 2021 Statement

JAMA
July 20, 2021, Vol 326, No. 3, Pages 207-286
https://jamanetwork.com/journals/jama/currentissue

 

Special Communication
Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating CircumstancesThe CONSERVE 2021 Statement
Aaron M. Orkin, MD, MSc, MPH; Peter J. Gill, MD, DPhil; Davina Ghersi, MD, PhD; et al.
free access
JAMA. 2021;326(3):257-265. doi:10.1001/jama.2021.9941
This Special Communication describes CONSERVE, a guideline developed to improve the transparency, quality, and completeness of reporting of trials and trial protocols that undergo important modifications in response to extenuating circumstances such as the COVID-19 pandemic.

Sharing Technology and Vaccine Doses to Address Global Vaccine Inequity and End the COVID-19 Pandemic

JAMA
July 20, 2021, Vol 326, No. 3, Pages 207-286
https://jamanetwork.com/journals/jama/currentissue

 

Viewpoint
Sharing Technology and Vaccine Doses to Address Global Vaccine Inequity and End the COVID-19 Pandemic
Matthew M. Kavanagh, PhD; Lawrence O. Gostin, JD; Madhavi Sunder, JD
free access
JAMA. 2021;326(3):219-220. doi:10.1001/jama.2021.10823
This Viewpoint offers 3 strategies to address inequity in pandemic vaccine response: surge funding, increased funding, and an agreement to share technology and allow countries to waive intellectual property rights in global public health emergencies.

Ethical Considerations of Offering Benefits to COVID-19 Vaccine Recipients

JAMA
July 20, 2021, Vol 326, No. 3, Pages 207-286
https://jamanetwork.com/journals/jama/currentissue

 

Ethical Considerations of Offering Benefits to COVID-19 Vaccine Recipients
Govind Persad, JD, PhD; Ezekiel J. Emanuel, MD, PhD
free access
JAMA. 2021;326(3):221-222. doi:10.1001/jama.2021.11045
This Viewpoint discusses why offering incentives for COVID-19 vaccination is not only ethical, but an important tool in increasing vaccine uptake, which benefits society as a whole.

Overview of the Issue

Journal of Health Care for the Poor and Underserved (JHCPU)
Volume 32, Number 2, May 2021 Supplement
https://muse.jhu.edu/issue/44396

 

Table of Contents
Overview of the Issue
Kevin B. Johnson, Tiffani J. Bright, Cheryl R. Clark
…The importance of techquity—defined as the strategic development and deployment of technology in health care and health to advance health equity—was even more apparent after the events of 2020. COVID-19 upended access to care and illuminated the impact of structural racism as a cause for a widening gap of access during the pandemic. Black Lives Matter became more than a trending hashtag on Twitter, or a movement resulting in peaceful protests and calls for policy reform: it put additional focus on the issue of race as a social and not a biological construct and called into question the rationale for common practices in health care that were triggered by race. A notable example was the emerging realization that kidney function assessment was tied to race and hardwired into many of our electronic health records. The real-world evidence around our lack of techquity was incontrovertible.
This Supplemental Issue of JHCPU provides articles that describe challenges to techquity, frameworks to improve the role of technology in care, and examples of how technology can transform health, public health, and health care…

Five priorities for universal COVID-19 vaccination

The Lancet
Jul 17, 2021 Volume 398 Number 10296 p185-276, e7
https://www.thelancet.com/journals/lancet/issue/current

 

Comment
Five priorities for universal COVID-19 vaccination
Adrien Abecassis
… On May 6, 2021, the Paris Peace Forum (PPF), an international platform dedicated to global governance, convened a high-level meeting, which included government officials and G20 sherpas to heads of states and governments, public health leaders, and members of non-governmental organisations and foundations from 15 countries, to deliberate on how to get closer to universal COVID-19 vaccination in a limited time. The group identified five priorities…

BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans

Nature
Volume 595 Issue 7868, 22 July 2021
https://www.nature.com/nature/volumes/595/issues/7868

 

Article | 27 May 2021
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
In a phase-I/II trial in healthy adults, the BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells against SARS-CoV-2 epitopes that are conserved in a wide range of currently circulating variants.
Ugur Sahin, Alexander Muik…Özlem Türeci

Evidence-informed policy for tackling adverse climate change effects on health: Linking regional and global assessments of science to catalyse action

PLoS Medicine
http://www.plosmedicine.org/
(Accessed 24 Jul 2021)

 

Evidence-informed policy for tackling adverse climate change effects on health: Linking regional and global assessments of science to catalyse action
Robin Fears, Khairul Annuar B. Abdullah, Claudia Canales-Holzeis, Deoraj Caussy, Andy Haines, Sherilee L. Harper, Jeremy N. McNeil, Johanna Mogwitz, Volker ter Meulen
Policy Forum | published 20 Jul 2021 PLOS Medicine
https://doi.org/10.1371/journal.pmed.1003719